周围型I-II期非小细胞肺癌SBRT单次与三次分割的随机II期试验
这项随机多中心II期试验纳入98例医学上无法手术的周围型T1/T2N0M0非小细胞肺癌患者,比较30 Gy单次与60 Gy三次分割SBRT。两组 thoracic grade 3+ 不良事件、局部控制、无进展生存和总生存均无差异;单次组社会功能和呼吸困难生活质量更优。
要点
- 30 Gy单次与60 Gy三次分割SBRT的胸部3级及以上不良事件无显著差异。
- 两组局部控制、无进展生存和总生存均无差异。
- 单次SBRT在6个月随访时社会功能和呼吸困难方面生活质量更优。
核心结论
- 30 Gy单次分割SBRT在毒性、局部控制、无进展生存和总生存方面与60 Gy三次分割等效。
研究设计与样本
- 随机、多中心、II期、两组临床试验,纳入98例活检证实的周围型T1/T2N0M0非小细胞肺癌且医学上无法手术的患者。
- 患者随机分配至30 Gy单次组(arm 1)或60 Gy三次组(arm 2),并按体能状态分层。
- 主要终点为常见不良事件术语标准胸部3级及以上不良事件;次要终点包括局部控制、无进展生存、总生存和生活质量。
主要发现
- 中位随访53.8个月,arm 1有8例(16%)发生胸部3级不良事件,arm 2有6例(12%),无4级或5级不良事件。
关键数值与推荐
- 30 Gy单次分割与60 Gy三次分割的胸部3级及以上不良事件分别为16%和12%。
临床怎么用
- 对于医学上无法手术的周围型I-II期非小细胞肺癌,30 Gy单次分割SBRT可作为60 Gy三次分割的等效选择。
- 单次分割SBRT可能在社会功能和呼吸困难方面带来生活质量获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Stereotactic body radiation therapy for early stage non-small cell lung cancer is a standard of care for medically inoperable patients. Our aim was to compare Common Terminology Criteria for Adverse Events thoracic grade 3 or higher adverse events (AEs) of 30 Gy in 1 fraction (arm 1) versus 60 Gy in 3 fractions (arm 2). METHODS AND MATERIALS: This was a randomized multi-institutional, phase 2, 2-arm clinical trial. Medically inoperable patients with biopsy-proven peripheral T1/T2N0M0 non-small cell lung cancer were enrolled. Patients were randomized to arm 1 or arm 2 and stratified by performance status. The primary endpoint was Common Terminology Criteria for Adverse Events thoracic grade 3 or higher AEs. Secondary endpoints were local control (LC), progression-free survival (PFS), overall survival (OS), and quality of life. RESULTS: Between September 2008 and April 2015, 98 patients were randomized. Median follow-up was 53.8 months. Ten patients were lost to follow-up, 1 in arm 1 and 9 in arm 2. Thoracic grade 3 AEs were experienced by 8 (16%) patients on arm 1 and 6 (12%) patients on arm 2. There were no grade 4 or 5 AEs. There were no differences in LC, PFS, or OS (P = .68, .86, and .94, respectively). Arm 1 reported better social functioning (P = .006) with less dyspnea (P = .016) in follow-up at 6 months. CONCLUSIONS: This randomized phase 2 study demonstrated that 30 Gy in 1 fraction was equivalent to 60 Gy in 3 fractions in terms of toxicity, LC, PFS, and OS. Quality of life measures of social functioning and dyspnea favored single-fraction SBRT.
引用
- Singh AK, Gomez-Suescun JA, Stephans KL, et al. One Versus Three Fractions of Stereotactic Body Radiation Therapy for Peripheral Stage I to II Non-Small Cell Lung Cancer: A Randomized, Multi-Institution, Phase 2 Trial. Int J Radiat Oncol Biol Phys. 2019. PMID: 31445956. doi:10.1016/j.ijrobp.2019.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。